drugset / Trial / NCT00959036
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of ATN-103 when administered to subjects with active rheumatoid arthritis compared with placebo. All subjects must be on a stable dose and route of methotrexate.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OZORALIZUMAB | Monoclonal antibody | 10 mg | — |
| Subject | OZORALIZUMAB | Monoclonal antibody | 30 mg | — |
| Subject | OZORALIZUMAB | Monoclonal antibody | 80 mg | — |
| Background | Methotrexate | Small molecule | — | — |